1. The S100A9-FTO Axis Directs Genetic Instability in Myelodysplastic Syndromes (MDS). (April 2017) Authors: Eksioglu, E.; Chen, X.; Basiorka, A.; Cheng, P.; Burnette, A.; Wei, M.; Zhang, L.; McGraw, K.; Liu, J.; Padron, E.; List, A.; Wei, S. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS. Issue 1 (April 2015) Authors: Eksioglu, E.A.; Chen, X.; Heider, K.H.; Rueter, B.; Burnette, A.; Wei, M.; McGraw, K.; Liu, J.; Basiorka, A.; Patel, P.; Lancet, J.; Komrokji, R.; List, A.; Wei, S. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 30 MDS GENETIC DAMAGE IS LINKED TO INFLAMMAGING INDUCED BONE MARROW HYPERGLYCEMIA. (April 2015) Authors: Wei, S.; Eksioglu, E.A.; Cluzeau, T.; Chen, X.; Basiorka, A.A.; Burnette, A.; Wei, M.; McGraw, K.L.; Padron, E.; List, A. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗